We are live on ! Find out more
CSII

Cardiovascular Systems, Inc.

Delisted

CSII was delisted on the 27th of April, 2023.

173 hedge funds and large institutions have $1.61B invested in Cardiovascular Systems, Inc. in 2021 Q2 according to their latest regulatory filings, with 18 funds opening new positions, 67 increasing their positions, 63 reducing their positions, and 19 closing their positions.

New
Increased
Maintained
Reduced
Closed

344% more call options, than puts

Call options by funds: $4.55M | Put options by funds: $1.02M

12% more capital invested

Capital invested by funds: $1.44B → $1.61B (+$175M)

6% more repeat investments, than reductions

Existing positions increased: 67 | Existing positions reduced: 63

1% less funds holding

Funds holding: 174173 (-1)

5% less first-time investments, than exits

New positions opened: 18 | Existing positions closed: 19

Holders
173
Holders Change
-1
Holders Change %
-0.57%
% of All Funds
3.01%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
67
Reduced
63
Closed
19
Calls
$4.55M
Puts
$1.02M
Net Calls
+$3.52M
Net Calls Change
+$3.98M
Name Holding Trade Value Shares
Change
Change in
Stake
BlackRock
1
BlackRock
New York
$298M -$4.26M -108,813 -2%
BCM
2
Brown Capital Management
Maryland
$256M +$72.2K +1,846 +0%
CIP
3
Champlain Investment Partners
Vermont
$146M -$604K -15,445 -0.4%
Vanguard Group
4
Vanguard Group
Pennsylvania
$113M +$1.11M +28,343 +1%
RC
5
RGM Capital
Florida
$83.3M +$12.9M +331,002 +20%
Janus Henderson Group
6
Janus Henderson Group
United Kingdom
$68.5M +$9.23M +235,986 +17%
State Street
7
State Street
Massachusetts
$64.6M +$2.82M +71,988 +5%
Wellington Management Group
8
Wellington Management Group
Massachusetts
$54.2M -$785K -20,078 -2%
Renaissance Technologies
9
Renaissance Technologies
New York
$43.8M -$3.2M -81,944 -7%
New York State Common Retirement Fund
10
New York State Common Retirement Fund
New York
$33M -$412K -10,528 -1%
Geode Capital Management
11
Geode Capital Management
Massachusetts
$32.9M +$570K +14,581 +2%
JP Morgan Chase
12
JP Morgan Chase
New York
$24M +$13.4M +342,370 +155%
Dimensional Fund Advisors
13
Dimensional Fund Advisors
Texas
$23.1M +$5.64M +144,339 +36%
ACH
14
ArrowMark Colorado Holdings
Colorado
$23M -$27K -691 -0.1%
Northern Trust
15
Northern Trust
Illinois
$20.6M -$477K -12,187 -2%
Invesco
16
Invesco
Georgia
$17.5M -$2.23M -57,067 -12%
GIM
17
Granahan Investment Management
Massachusetts
$17.3M -$2.6M -66,421 -14%
PCM
18
Peregrine Capital Management
Minnesota
$15.2M -$743K -18,994 -5%
Bank of New York Mellon
19
Bank of New York Mellon
New York
$14.9M -$1.44M -36,851 -10%
GPGA
20
Grandeur Peak Global Advisors
Utah
$13.9M +$2.86M +73,227 +29%
Principal Financial Group
21
Principal Financial Group
Iowa
$12.5M -$5.63K -144 -0%
Charles Schwab
22
Charles Schwab
California
$11.8M +$183K +4,683 +2%
GKIM
23
GW&K Investment Management
Massachusetts
$8.79M -$158K -4,040 -2%
EAM
24
Eagle Asset Management
Florida
$7.69M +$96.8K +2,475 +1%
Ameriprise
25
Ameriprise
Minnesota
$7.44M -$722K -18,474 -10%

CSII Hedge Fund Activity: Q2 2021 in Review

173 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cardiovascular Systems, Inc. (CSII) for Q2 2021, worth a combined $1.61B — up 12% from $1.44B a quarter earlier.

Sellers outnumbered buyers: 19 funds closed out of CSII and 18 opened new positions — a net loss of 1 holder — while 63 trimmed existing stakes and 67 added.

The largest buyer was JP Morgan Chase, adding an estimated $13.4M. The largest seller was Frontier Capital Management, exiting entirely with an estimated $7.43M sold.

  • 173 institutional investors held Cardiovascular Systems, Inc. (CSII) as of Q2 2021, down from 174 in Q1 2021.
  • Funds reported $1.61B of Cardiovascular Systems, Inc. stock for Q2 2021, up 12% quarter-over-quarter.
  • 18 funds opened new Cardiovascular Systems, Inc. positions in Q2 2021 and 19 closed out, a net change of -1 holder.
  • The largest Cardiovascular Systems, Inc. buyer in Q2 2021 was JP Morgan Chase, an estimated $13.4M added.
  • The largest Cardiovascular Systems, Inc. seller in Q2 2021 was Frontier Capital Management, an estimated $7.43M sold.

Based on aggregated 13F filings for Q2 2021.